Pharmaco Imaging and Theranostic Agents — Year 2016 (Q3695265)

From EU Knowledge Graph
Revision as of 19:04, 18 November 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in en: translated_label)
Jump to navigation Jump to search
Project Q3695265 in France
Language Label Description Also known as
English
Pharmaco Imaging and Theranostic Agents — Year 2016
Project Q3695265 in France

    Statements

    country
    France
    0 references
    EU contribution
    182,127.0 Euro
    0 references
    budget
    404,728.53 Euro
    0 references
    co-financing rate
    45.0 percent
    0 references
    start time
    18 March 2016
    0 references
    end time
    31 October 2018
    0 references
    beneficiary name (string)
    Université de Bourgogne
    0 references
    summary
    Le développement de nouveaux médicaments est un processus de plus en plus coûteux et compliqué sur le plan réglementaire comme technique; l’imagerie médicale dans ce contexte représente un axe stratégique pour l’économie. (French)
    0 references
    The development of new drugs is an increasingly costly and technically complicated regulatory process; medical imaging in this context is a strategic focus for the economy. (English)
    point in time
    18 November 2021
    0 references

    Identifiers

    French Kohesio ID
    BG0005829
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q3695265&oldid=15294104"